TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE BONE MARROW BIOPSY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASE SPECIALLY CANCER
5.1.2 INCREASING DIAGNOSIS RATE OF EARLY DETECTION
5.1.3 ADEQUATE REIMBURSEMENT POLICIES
5.1.4 INCREASING AWARENESS PROGRAM AND INITIATIVE
5.2 RESTRAINTS
5.2.1 HIGH COST OF BONE MARROW BIOPSY TESTING
5.2.2 STRINGENT REGULATORY FRAMEWORK AND GUIDELINES
5.3 OPPORTUNITIES
5.3.1 EXTENSIVE RESEARCH AND DEVELOPMENT ACTIVITIES
5.3.2 INTRODUCTION OF CUTTING EDGE BIOPSY DEVICES
5.3.3 HUGE MARKET POTENTIAL IN DEVELOPING COUNTRIES
5.4 CHALLENGES
5.4.1 LACK OF MEDICAL INFRASTRUCTURE IN DEVELOPING COUNTRIES
5.4.2 SIDE EFFECTS AND RISKS ASSOCIATED WITH BONE MARROW BIOPSY
5.4.3 SHORTAGE OF SKILLED PHYSICIAN
6 EUROPE BONE MARROW BIOPSY MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 NEEDLES
6.2.1 BY TYPE
6.2.1.1 JAMSHIDI NEEDLE
6.2.1.2 TREPHINE BIOPSY NEEDLES
6.2.1.3 SALAH BONE MARROW ASPIRATION NEEDLE
6.2.1.4 KLIMA STERNAL NEEDLE
6.2.2 BY MODALITY
6.2.2.1 DISPOSABLE
6.2.2.2 REUSABLE
6.2.3 BY ERGONOMICS
6.2.3.1 SHARP
6.2.3.2 CHIBA
6.2.3.3 FRANSEEN
6.2.3.4 QUINCKE
6.2.3.5 BLUNT
6.2.3.6 OTHERS
6.3 INSTRUMENTS
6.3.1 ANALYZER
6.3.2 FLOW CYTOMETER
6.3.3 PCR MACHINE
6.3.4 OTHERS
6.4 BIOPSY GUN
6.5 PROCEDURE TRAYS
6.6 OTHERS
7 EUROPE BONE MARROW BIOPSY MARKET, BY PROCEDURE TYPE
7.1 OVERVIEW
7.2 HIP BIOPSY
7.3 BREASTBONE (STERNUM) BIOPSY
7.4 PERCUTANEOUS TREPHINE BIOPSY
7.5 TIBIA (SHIN) BIOPSY
7.6 OTHERS
8 EUROPE BONE MARROW BIOPSY MARKET, BY BIOPSY TYPE
8.1 OVERVIEW
8.2 CORE NEEDLE BIOPSY
8.3 VACUUM-ASSISTED BIOPSY (VAB)
8.4 FINE NEEDLE ASPIRATION BIOPSY
9 EUROPE BONE MARROW BIOPSY MARKET, BY SITE
9.1 OVERVIEW
9.2 POSTERIOR ILIAC CREST
9.3 ANTERIOR ILIAC CREST
9.4 CALCANEUS
9.5 DISTAL TIBIA
9.6 PROXIMAL TIBIA
9.7 PROXIMAL HUMERUS
9.8 OTHERS
10 EUROPE BONE MARROW BIOPSY MARKET, BY TECHNIQUE
10.1 OVERVIEW
10.2 FLOW CYTOMETRY
10.3 FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
10.4 POLYMERASE CHAIN REACTION (PCR)
10.5 KARYOTYPE TEST
10.6 OTHERS
11 EUROPE BONE MARROW BIOPSY MARKET, BY AGE
11.1 OVERVIEW
11.2 GERIATRIC
11.3 ADULT
11.4 PEDIATRIC
12 EUROPE BONE MARROW BIOPSY MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 LYMPHOMA DISEASE
12.3 LEUKEMIA
12.3.1 CHRONIC LYMPHOCYTIC LEUKEMIA
12.3.2 ACUTE MYELOID LEUKEMIA
12.3.3 CHRONIC MYELOID LEUKEMIA
12.3.4 ACUTE LYMPHOCYTIC LEUKEMIA
12.4 POLYCYTHEMIA VERA
12.5 MULTIPLE MYELOMA
12.6 THROMBOCYTHEMIA
12.7 MYELOFIBROSIS
12.8 APLASTIC ANEMIA
12.9 OTHERS
13 EUROPE BONE MARROW BIOPSY MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC CENTERS
13.4 AMBULATORY SURGICAL CENTERS
13.5 ACADEMIC AND RESEARCH ORGANIZATIONS
13.6 OTHERS
14 EUROPE BONE MARROW BIOPSY MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
15 EUROPE BONE MARROW BIOPSY MARKET, BY GEOGRAPHY
15.1 EUROPE
15.1.1 GERMANY
15.1.2 FRANCE
15.1.3 U.K.
15.1.4 ITALY
15.1.5 SPAIN
15.1.6 NETHERLANDS
15.1.7 SWITZERLAND
15.1.8 BELGIUM
15.1.9 RUSSIA
15.1.10 TURKEY
15.1.11 REST OF EUROPE
16 EUROPE BONE MARROW BIOPSY MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: EUROPE
17 EUROPE BONE MARROW BIOPSY MARKET: SWOT ANALYSIS
17.1 SWOT ANALYSIS
17.1.1 STRENGTH: - WIDE PRODUCT PORTFOLIO
17.1.2 STRENGTH: - STRONG EUROPE PRESENCE
17.1.3 STRENGTH: - EXTENSIVE RESEARCH AND DEVELOPMENT ACTIVITIES
17.1.4 WEAKNESS: - SINGLE SUPPLIER
17.1.5 WEAKNESS: - PRODUCT RECALL
17.1.6 WEAKNESS: - OBSOLETE TECHNOLOGIES
17.1.7 OPPORTUNITY: - EXPANDING BUSINESS THOROUGH THEIR SUBSIDIARIES
17.1.8 OPPORTUNITY: - ACQUISITION
17.1.9 THREAT: - FDA STANDARDS/ REGULATORY AUTHORITIES STRINGENT RULES
17.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
18 COMPANY PROFILE
18.1 BD
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENT
18.2 MEDTRONIC
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENT
18.3 ARGON MEDICAL
18.3.1 COMPANY SNAPSHOT
18.3.2 COMPANY SHARE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENT
18.4 MERIT MEDICAL SYSTEMS
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 CARDINAL HEALTH
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENT
18.6 TELEFLEX INCORPORATED
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENT
18.7 BIOMEDICAL SRL
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 BPB MEDICA
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 COOK
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.10 EGEMEN INTERNATIONAL
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 HIPROVE
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 JORGENSEN LABS
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 MEDICAL DEVICES BUSINESS SERVICES, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENT
18.14 MDL SRL
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SHANGHAI MEKON MEDICAL DEVICES CO., LTD.
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 SOMATEX MEDICAL TECHNOLOGIES GMBH
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 STERYLAB S.R.L.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 TSUNAMI MEDICAL SRL
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENT
18.19 WELLGO MEDICAL PRODUCTS GMBH
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.20 ZAMAR CARE
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 CONCLUSION
21 RELATED REPORTS